Clinical Application of Phage Immunoprecipitation Sequencing to Diagnose Enterovirus D68 as the Underlying Etiology in a Case of Guillain-Barré Syndrome - Scorecard - MDSpire
Advertisement
Clinical Application of Phage Immunoprecipitation Sequencing to Diagnose Enterovirus D68 as the Underlying Etiology in a Case of Guillain-Barré Syndrome
Clinical Scorecard: Utilization of Phage Immunoprecipitation Sequencing for Diagnosing Enterovirus D68 as a Contributing Factor in Guillain-Barré Syndrome Cases
Immune-mediated attack on peripheral nerves via antibodies triggered by molecular mimicry following infection
Target Population
Pediatric patients with acute flaccid paralysis and suspected antecedent infection
Care Setting
Pediatric intensive care unit (PICU) and specialized diagnostic laboratories
Key Highlights
GBS often follows respiratory or gastrointestinal infections, with enterovirus D68 recently implicated as a trigger.
Phage immunoprecipitation sequencing (PhIP-Seq) can detect intrathecal antibodies in cerebrospinal fluid to support etiological diagnosis when direct pathogen detection is inconclusive.
A severe pediatric GBS case with prior EV-D68 respiratory infection was confirmed by detecting CSF antibodies using PhIP-Seq.
Guideline-Based Recommendations
Diagnosis
Consider GBS diagnosis in patients with progressive symmetric ascending weakness and pain, especially following recent infection.
Use clinical examination including reflex testing and cranial nerve assessment.
Employ MRI imaging to detect nerve root enhancement supporting diagnosis.
Utilize PhIP-Seq for detecting intrathecal antibodies against suspected pathogens when CSF PCR is negative or inconclusive.
Management
Monitor respiratory function closely due to risk of respiratory failure requiring intubation.
Provide supportive care in PICU including respiratory support and vasopressors for autonomic instability.
Early recognition and treatment of GBS variants such as AIDP are critical.
Monitoring & Follow-up
Regular neurological assessments to track progression of weakness and cranial nerve involvement.
Monitor respiratory status and autonomic function vigilantly.
Follow antibody levels and clinical response where applicable.
Risks
Rapid progression to respiratory failure and cranial nerve dysfunction.
Potential for autonomic instability requiring vasopressor support.
Diagnostic delays due to low pathogen yield in CSF testing.
Patient & Prescribing Data
Pediatric patients with suspected GBS and antecedent respiratory infections including EV-D68
PhIP-Seq can aid in confirming infectious etiology to guide diagnosis and management, especially when conventional CSF pathogen detection is negative.
Clinical Best Practices
Obtain paired serum and CSF samples early in the disease course for antibody profiling.
Use PhIP-Seq to detect intrathecal antibody production against enterovirus D68 and other pathogens.
Integrate clinical, imaging, and advanced serological data for comprehensive diagnosis.
Provide multidisciplinary care in PICU with readiness for respiratory and autonomic support.
by Fang Fang Li, Alison Faber, Jessica M Caleta, David M Goldfarb, Inna Sekirov, Natalie A Prystajecky, Jocelyn A Srigley, Ram Mishaal, Agatha N Jassem